Company
Mammoth Biosciences
Developing in vivo gene editing therapeutics to transform patient lives.
Also known as Mammoth Biosciences, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Brisbane, California, United States
- Legal name
- Mammoth Biosciences, Inc.
- mammoth.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are scientists, engineers, entrepreneurs, and dreamers who are building the CRISPR platform to deliver on the full promise of genetic medicine.
Funding snapshot
- Total raised
- $20.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.4M2018-08-10
Funding rounds
- Round, 2018
- $7.4M2018-08-10, SEC form D sold, 4 investors
- Round, 2018
- $13.2M2018-05-15, SEC form D sold, 28 investors
Products
- Web
- Diagnostics
- Web
- MB-111
- Web
- NanoCas
- Web
- Protein Discovery and Engineering
- Web
- Therapeutics
Loading relationship preview